SCHEMBL17293702

SCHEMBL17293702

Nc1ccc(Cl)c(S(=O)(=O)C2CC(F)C2)c1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 18/20 0.38
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
RECQL P46063 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17293700 1.00 CXCR2 (0.38) CXCR2ALDH1A1CYP3A4THRBHPGD
SCHEMBL17293762 0.86 CXCR2 (0.40) CXCR2ALDH1A1CYP3A4THRBHPGD
SCHEMBL17293763 0.86 CXCR2 (0.40) CXCR2ALDH1A1CYP3A4THRBHPGD
SCHEMBL17293832 0.84 CXCR2 (0.39) CXCR2
SCHEMBL17293833 0.84 CXCR2 (0.39) CXCR2
SCHEMBL22606117 0.84 CXCR2 (0.44) CXCR2
SCHEMBL17309562 0.84 CA12 (0.33) CXCR2CA12CA1CA2CA4
SCHEMBL19065958 0.82 CXCR2 (0.41) CXCR2
SCHEMBL19065960 0.82 CXCR2 (0.41) CXCR2
SCHEMBL19065959 0.82 CXCR2 (0.41) CXCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148963-A1 1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2017-04-05 EP disclosed
WO-2015181186-A1 1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2015-12-03 WO disclosed